B&M European Value Retail plc (BME)
London Exchange · UK · prices in GBX · close of 22 Oct 2026
Key indicators
| Last close | GBX 275.20 |
|---|---|
| 52-week range | 154.00 – 287.20 |
| Return, 1 month / 3 months | +9.3% / +28.8% |
| Return, 1 year / 3 years | +61.5% / −36.3% |
| Trend | Uptrend |
| RSI (14) | 62 |
| Volatility (1 year) | 41.4% |
| Worst drawdown (1 year) | -19.8% |
| Average daily value traded | 1,159.22M GBX |
| Dividend yield | 3.5% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
B&M European Value Retail plc runs discount variety stores that offer household goods, groceries, toys, garden supplies and seasonal products at low prices. Its shops serve everyday shoppers in the United Kingdom, where it trades under the B&M name, and it also operates the Heron Foods convenience chain and the Babou stores in France. The business is built around a wide assortment of branded and own-label goods sold at value prices, and it is headquartered in Luxembourg.
On this site B&M European Value Retail plc appears as a stock on the London Exchange (UK), code BME, with prices in pence sterling (GBX). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
B&M European Value Retail plc (BME) trades on the London Exchange in UK. It last closed at GBX 275.20 on 22 October 2026.
Its price-based Market X-Ray is 82 out of 100 (a strong price profile), ranking 29 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 61.5% and over the last three months it rose 28.8%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 92 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 37.1% | ||
| From 52-week high | -3.8% | ||
| Momentum | 91 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 28.8% | ||
| 6-month return | 58.8% | ||
| 12-month return, skipping the last month | 47.7% | ||
| Stability (higher is calmer) | 56 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 41.4% | ||
| Worst drawdown, 1 year (smaller is calmer) | -19.8% | ||
| Liquidity | 97 · Strong | Trades actively. | |
| Average daily value traded | 1,159.22M GBX | ||
| Zero-volume days | 0.0% | ||
| Income | 72 · Strong | Dividend is high and has been paid regularly. | |
| Dividend yield | 3.5% | ||
| Years with dividends | 6 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
- Liquidity: Trades actively.
- Income: Dividend is high and has been paid regularly.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | −1.6% |
|---|---|
| 1 month | +9.3% |
| 3 months | +28.8% |
| 6 months | +58.8% |
| 1 year | +61.5% |
| 3 years | −36.3% |
| 5 years | −34.4% |
Signals
| 50-day / 200-day average | 247.03 / 200.70 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 8.54 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 11 Jun 2026 | GBP 0.0610 |
| 20 Nov 2025 | GBP 0.0350 |
| 26 Jun 2025 | GBP 0.0970 |
| 16 Jan 2025 | GBP 0.1500 |
| 21 Nov 2024 | GBP 0.0530 |
| 27 Jun 2024 | GBP 0.0960 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.